Back

prof. dr. D.E. Grobbee

Full Professor
prof. dr. D.E. Grobbee
  • Department of Epidemiology
  • Julius Center Research Program Cardiovascular Epidemiology

Research Programs

Circulatory Health

Biography

Biography

Biographical Sketch

Diederick (Rick) E. Grobbee was trained as a medical doctor at Utrecht University. He then conducted PhD research in the field of hypertension at Erasmus University in Rotterdam (12/83-6/1986). After a residency in Internal Medicine, he returned to the Erasmus University as an associate professor and then Full professor of Clinical Epidemiology (1993). In Rotterdam he was responsible for the cardiovascular disease research program of the Department of Epidemiology, and was one of the founders of the Rotterdam Study (www.epib.nl/research/ergo.htm). In 1996 he was appointed professor of Clinical Epidemiology at Utrecht University and founded of the Julius Center for Health Sciences and Primary Care (1996), a division of the University Medical Center Utrecht (UMCU) currently employing approximately 500 staff (www.juliuscenter.nl). In 2008 he founded Julius Clinical Ltd., a full service Academic Clinical Research Organization (www.juliusclinical.com) of which he serves as Chief Medical Officer and Statutory Director. At the University Medical Center Utrecht, he just finished his term as the chair of the Center for Circulatory Health at the UMCU governing cardiovascular patient care, research and education. Previous positions include director of the Rotterdam Medical Research Foundation, member of the board of Erasmus University Medical Center, and visiting Associate Professor at Harvard University, Boston. He holds honorary appointments in Sydney and Kuala Lumpur.  At Utrecht University he was appointed Distinguished University Professor in 2010.

Rick Grobbee has been a (principal) investigator in many large-scale epidemiologic studies and randomized intervention trials relating to the prevention and treatment of cardiovascular, cardiometabolic, and cardiorenal disease. In addition he works on the principles and methods of treatment research, trial design and (big-) data analysis. In the Netherlands he was member of the supervisory board of the Netherlands Heart Foundation and acted in several roles in committees of the National Research Council (ZonMW). He is chair of the Dutch National Research Agenda (NWA) route "Prevention". He has been listed in the top 100 global most influential biomedical researchers (Eur J Clin Invest 2013 Dec;43(12):1339-65) and has consistently been ranked as highly cited author by Web of Science over the last decades.

Rick Grobbee has been on the editorial boards of several journals and (inter) national scientific, search, and site-visit committees. Current journal roles include editor-in-chief of Global Heart (https://globalheartjournal.com/), senior consulting editor of the European Journal of Preventive Cardiology of which he served as editor-in-chief for eight years. He is immediate past-president of the European Association for Preventive Cardiology and member of the board of the European Society of Cardiology (ESC) and chair of the ESC Global Affairs Committee. He is member of the board of the World Heart Federation Rick Grobbee is fellow of the Royal Dutch Academy of Sciences and served as the chair of its Medical Section and Advisory Council for the Medical Sciences. He is honorary fellow of the Indonesian Heart Association and of the Romanian Society of Cardiology.  In recent years his attention has increasingly been directed towards global circulatory health (www.globalhealth.eu ), and on-line education for which he founded Elevate, a platform providing global post graduate courses, masters programs and eductional consultancy (www.elevatehealth.eu ).  Rick Grobbee was a recipient of a 2019 NWO Gravitation Award "Exposomics" and current coordinator of three EU grants. In 2017 he was knighted by the Dutch King (Knight in the Order of the Dutch Lion). To date, Prof. Grobbee has authored or co-authored over 1,300 scientific papers (PubMed), chapters, and books, and has supervised more than 150 PhD fellows. His Hirsch index (Web of Science) is 151.

 

Side Activities

 

  • Chief Scientific Officer and Statutory Director, Julius Clinical Ltd. Academic Clinical Research Organization (0.5 Fte)
  • Director, Utrecht University MSc and PhD in Epidemiology Programmes
  • Chair ("Boegbeeld"), National Research Agenda (NWA) Route Health Research, Prevention and Treatment
  • Member, Board of Studies, Graduate School Life Sciences, Utrecht University
  • Fellow, Royal Dutch Academy of Sciences
  • Fellow, European Society of Cardiology
  • Member, Board, European Society of Cardiology
  • Member, Board, World Heart Federation
  • Chair, Global Affairs Committee, European Society of Cardiology
  • Member, Practice Guidelines Committee, European Society of Cardiology
  • Past-President, European Association for Cardiovascular Prevention and Rehabilitation
  • Member Executive Board, European Association for Cardiovascular Prevention and Rehabilitation
  • Chair, International Scientific Advisory Board, BBMRI (Biobanking Netherlands)
  • Editor in Chief, Global Heart
  • Senior Consulting Editor, European Journal of Cardiovascular Prevention and Rehabilitation
  • Member, Editorial Board Netherlands Journal of Medicine
  • Member, Editorial Board, Current Cardiovascular Risk Reports
  • Member, Editorial Board Cardiovascular Risk
  • Member, Various Scientific Advisory, Safety Monitoring en Adjudication Committees International Clinical Trials

 

Fellowship and Awards

  • 2008 Prevention award. German Society of Cardiology
  • 2008 Catharijne Prize
  • 2009 David de Wied lecture
  • 2009 Fellow of the Netherlands Royal Academy of Sciences
  • 2010 Distinguished University Professor of International Health Sciences and Global Health, Utrecht University
  • 2016 Honorary Fellow, Indonesian Heart Association
  • 2016 Romanian Society of Cardiology
  • 2017 Knight. Order of the Dutch Lion

Research Output (1671)

Diagnostic performance and clinical implications for enhancing a hybrid quantitative flow ratio-FFR revascularization decision-making strategy

Peper Joyce, van Hamersvelt Robbert W, Rensing Benno J W M, van Kuijk Jan-Peter, Voskuil Michiel, Berg Jurriën M Ten, Schaap Jeroen, Kelder Johannes C, Grobbee Diederick E, Leiner Tim, Swaans Martin J dec 2021, In: Scientific Reports. 11

Early health economic analysis of 1.5 T MRI-guided radiotherapy for localized prostate cancer: Decision analytic modelling

Hehakaya Charisma, van der Voort van Zyp Jochem, Vanneste Ben, Grutters Janneke, Grobbee Diederick, Verkooijen Lenny, Frederix GW aug 2021, In: Radiotherapy & Oncology. 161 , p. 74-82

Erratum: Unexpected low frequency of respiratory symptoms in an HIV-positive urban sub-Saharan population compared to an HIV-negative control group

Kummerow Maren, Shaddock Erica J, Klipstein-Grobusch Kerstin, Barth Roos B, Grobbee Diederick E, Francois Venter W D, Feldman Charles, Vos Alinda 19 apr 2021, In: Southern African Journal of HIV Medicine. 22 1 p.

Poor cardiovascular health is associated with subclinical atherosclerosis in apparently healthy sub-Saharan African populations:an H3Africa AWI-Gen study

Nonterah Engelbert A, Crowther Nigel J, Oduro Abraham, Agongo Godfred, Micklesfield Lisa K, Boua Palwendé R, Choma Solomon S R, Mohamed Shukri F, Sorgho Herman, Tollman Stephen M, Norris Shane A, Raal Frederick J, Grobbee Diederick E, Ramsay Michelé, Bots Michiel L, Klipstein-Grobusch Kerstin, 10 feb 2021, In: BMC Medicine. 19 12 p.

Electrocardiographic and echocardiographic abnormalities in urban African people living with HIV in South Africa

Roozen Geert V T, Meel Ruchika, Peper Joyce, Venter William D F, Barth Roos E, Grobbee Diederick E, Klipstein-Grobusch Kerstin, Vos Alinda G 2 feb 2021, In: PLoS ONE. 16 16 p.

The Duty to Support Learning Health Systems:A Broad Rather than a Narrow Interpretation

van der Graaf R, van Dijk Wouter, Laurijssen Sara J M, Schuit Ewoud, Grobbee DE, de Vries Martine C jan 2021, In: The American Journal of Bioethics. 21 , p. 14-16 3 p.

Can an mhealth clinical decision-making support system improve adherence to neonatal healthcare protocols in a low-resource setting?

Amoakoh Hannah Brown, Klipstein-Grobusch Kerstin, Agyepong Irene Akua, Amoakoh-Coleman Mary, Kayode Gbenga A, Reitsma J B, Grobbee Diederick E, Ansah Evelyn K 27 dec 2020, In: BMC Pediatrics. 20 , p. 1471-2431 960 p.

Ideal Cardiovascular Health Index and Its Determinants in a Rural South African Population

Ketelaar E J, Vos A G, Godijk N G, Scheuermaier K, Devillé W, Tempelman H, Coutinho R A, Venter W D F, Grobbee D E, Klipstein-Grobusch K 25 nov 2020, In: Global Heart. 15

Prevalence of chronic kidney disease and risk factors in North-Central Nigeria:a population-based survey

Olanrewaju Timothy Olusegun, Aderibigbe Ademola, Popoola Ademola Alabi, Braimoh Kolawole Thomas, Buhari Mikhail Olayinka, Adedoyin Olanrewaju Timothy, Kuranga Sulyman Alege, Biliaminu Sikiru Abayomi, Chijioke Adindu, Ajape Abdulwahab Akanbi, Grobbee Diederick E, Blankestijn Peter J, Klipstein-Grobusch Kerstin, 10 nov 2020, In: BMC Nephrology. 21

Problems and Promises of Introducing the Magnetic Resonance Imaging Linear Accelerator Into Routine Care:The Case of Prostate Cancer

Hehakaya Charisma, Van der Voort van Zyp Jochem R, Lagendijk Jan J W, Grobbee Diederick E, Verkooijen Helena M, Moors Ellen H M 2 sep 2020, In: Frontiers in oncology. 10 11 p.

All research output

Thank you for your review!

Has this information helped you?

Please tell us why, so that we can improve our website.

Working at UMC Utrecht

Contact

Emergency?

Directions

Appointments

Practical

umcutrecht.nl maakt gebruik van cookies

Deze website maakt gebruik van cookies Deze website toont video’s van o.a. YouTube. Dergelijke partijen plaatsen cookies (third party cookies). Als u deze cookies niet wilt kunt u dat hier aangeven. Wij plaatsen zelf ook cookies om onze site te verbeteren.

Lees meer over het cookiebeleid

Akkoord Nee, liever niet